Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging.
about
Therapy response with diffusion MRI: an updateMeta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapyMR Imaging Biomarkers in Oncology Clinical TrialsCurrent and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy.Gradient nonlinearity correction to improve apparent diffusion coefficient accuracy and standardization in the american college of radiology imaging network 6698 breast cancer trialDiffusion MRI in early cancer therapeutic response assessment.Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypesPre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review.The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic reviewBreast cancer spatial heterogeneity in near-infrared spectra and the prediction of neoadjuvant chemotherapy response.Texture analysis on MR images helps predicting non-response to NAC in breast cancerMultiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response.High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer.Dynamic contrast-enhanced MR imaging in a phase Ⅱ study on neoadjuvant chemotherapy combining Rh-endostatin with docetaxel and epirubicin for locally advanced breast cancerQuantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations.Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.Diffusion weighted magnetic resonance imaging of the breast: protocol optimization, interpretation, and clinical applications.Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography.High resolution in vivo characterization of apparent diffusion coefficient at the tumor-stromal boundary of breast carcinomas: a pilot study to assess treatment response using proximity-dependent diffusion-weighted imaging.Oncologic applications of diffusion-weighted MRI in the body.Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.Utilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy.Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancerMagnetic resonance imaging tumor regression shrinkage patterns after neoadjuvant chemotherapy in patients with locally advanced breast cancer: Correlation with tumor biological subtypes and pathological response after therapy.Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy.Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis.Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis.DCE- and DW-MRI as early imaging biomarkers of treatment response in a preclinical model of triple negative breast cancer.A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features.Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis.Evaluating the diagnostic sensitivity of computed diffusion-weighted MR imaging in the detection of breast cancer.Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient.The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy.MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index.Histogram analysis of apparent diffusion coefficients after neoadjuvant chemotherapy in breast cancer.
P2860
Q26851700-E31A648B-9FAF-4EF2-BEF8-862786457F9FQ27024544-BCA4E8C8-0938-4A99-B37D-D00015FC9E82Q30364608-1E021FA7-D0C4-4E6E-8B27-B80825836A14Q30460977-F76BF127-A524-4010-A4CB-D3C0D9DD0792Q30908332-8541D073-5F94-473D-BEF5-3ADEA951D626Q31037179-7FC07153-A76A-414D-9D54-6A1F12291633Q33712925-456EA320-9B2B-47E3-B8D6-50476698C118Q34415629-ECD75822-E6BE-48D0-9E92-660CDF88212AQ34566213-C3CCAE32-4A67-4FF6-8FBB-9C5FB1259660Q35462441-DA47AACC-E7F6-4D8C-BC2E-090EBEB1FD55Q35737991-4110A87B-D4AC-4886-8675-04ED81EE652BQ35754699-18F80439-1391-47B8-B1E8-DB6C7B2028BFQ35866592-6CABF332-1B5A-4902-B1B4-FFF8281DB3ACQ35869462-CC9F68E9-5D0E-40F8-A44A-72559321AD05Q36540092-E4C60847-06D8-4A2B-8ACB-84930C6E72DBQ36689284-DE446023-5743-411D-BBC5-4591798EC3C0Q36779852-4398A6BF-CA2F-4523-B692-057385E54B8CQ37087591-B8C057B1-4E26-4316-AC33-740570989C04Q37300368-C09E3315-5634-42DC-8092-929B3A627404Q37624053-2360F79B-1CDE-49F4-AAF9-A721ABAD6BB4Q37685154-DE8F6635-4F28-4892-8DA6-DF40A6EF4663Q37697787-A131E53A-1937-41D3-8F25-6938D3AFD8ABQ37978220-9959350B-64E1-47CE-ADAC-893AB8F52546Q38000076-9AD70675-0332-478E-B98F-A641514D1EA1Q38104997-E9BE7AA0-C503-4751-8CC2-07C150461BCDQ38442666-54F7CB1A-22C9-468B-B689-F4778227C98EQ38960247-0EA887A3-14E6-43CB-9DED-EA1794D3772CQ40276958-092D1D9F-8B53-4E57-9739-550E34AC74E7Q44491240-0AC4CEE7-3B5D-481B-938B-46EEA3D3C893Q47283342-D6A297BD-AAE8-4D72-9DC0-BD93A651E281Q47287018-844BAD98-97AB-44FA-A612-7F57FCB540A8Q47670339-F4ADC7D6-0013-489A-926A-6A3298E19B2CQ47766584-277EDD29-12B5-4B1C-A6F9-4C671D8D6FD5Q47941822-B8156852-E15B-4C80-B7C5-3FEA27C75A71Q50308589-6A6C65F2-30F9-4977-8A26-B5AE61DD5E58Q50736046-5F586F95-33A3-4BD2-87FE-E2DB66B9959EQ53015150-A17B012E-FA49-4067-8D42-FD6B61221785Q53063063-80610801-D8ED-4C8C-9563-E3BC8F6E098CQ53582174-386D0B31-CBA3-4702-B15E-E0C1ED1993CCQ53582375-8D13165B-C841-4041-835D-5AFFA9949A7B
P2860
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@ast
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@en
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@nl
type
label
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@ast
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@en
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@nl
prefLabel
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@ast
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@en
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@nl
P2093
P2860
P1433
P1476
Neoadjuvant chemotherapy in br ...... diffusion-weighted MR imaging.
@en
P2093
A Fangberget
L B Nilsen
M M Holmen
O Engebraaten
P2860
P2888
P304
P356
10.1007/S00330-010-2020-3
P407
P577
2010-12-03T00:00:00Z